Home > Cashflow Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Cashflow Statement

NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Profit Before Tax₹41 Cr₹42 Cr₹36 Cr₹-63 Cr₹12 Cr
Adjustment ₹13 Cr₹10 Cr₹13 Cr₹102 Cr₹8.18 Cr
Changes In working Capital ₹-35 Cr₹23 Cr₹-9.81 Cr₹-19 Cr₹-5.72 Cr
Cash Flow after changes in Working Capital ₹19 Cr₹75 Cr₹39 Cr₹20 Cr₹15 Cr
Cash Flow from Operating Activities ₹18 Cr₹75 Cr₹38 Cr₹17 Cr₹14 Cr
Cash Flow from Investing Activities ₹-3.96 Cr₹-27 Cr₹-2.88 Cr₹-20 Cr₹-21 Cr
Cash Flow from Financing Activities ₹-2.13 Cr₹-7.78 Cr₹-1.67 Cr₹-22 Cr₹5.74 Cr
Net Cash Inflow / Outflow ₹11 Cr₹39 Cr₹34 Cr₹-25 Cr₹-0.81 Cr
Opening Cash & Cash Equivalents ₹77 Cr₹38 Cr₹4.18 Cr₹29 Cr₹3.29 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹89 Cr₹77 Cr₹38 Cr₹4.18 Cr₹2.48 Cr

Compare Cashflow Statement of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹277.4 Cr -2.7% -6.4% -15.2% Stock Analytics
KAVERI SEED COMPANY ₹3,559.6 Cr -4.5% -10.4% -40.2% Stock Analytics
VENKYS (INDIA) ₹2,354.1 Cr -1.4% 9.3% 12.9% Stock Analytics
AVT NATURAL PRODUCTS ₹1,306.0 Cr -7% -3% 13% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹894.0 Cr -6.7% -2.7% NA Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹514.8 Cr -1% 6.7% -2% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.7%

-6.4%

-15.2%

SENSEX

-1.6%

-4.7%

-8.3%


You may also like the below Video Courses